Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) posted its earnings results on Thursday. The company reported $1.09 earnings per share for the quarter, meeting the consensus estimate of $1.09, Briefing.com reports. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The business had revenue of $283.79 million for the quarter, compared to analyst estimates of $282.09 million. During the same quarter in the previous year, the business posted $1.07 EPS. The business's quarterly revenue was down .9% on a year-over-year basis. Prestige Consumer Healthcare updated its FY 2025 guidance to 4.460-4.460 EPS and its FY25 guidance to $4.40 to $4.46 EPS.
Prestige Consumer Healthcare Stock Up 0.3 %
Shares of PBH stock traded up $0.28 during mid-day trading on Friday, reaching $80.37. 367,423 shares of the company were exchanged, compared to its average volume of 247,025. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23. The business's 50 day simple moving average is $72.55 and its 200 day simple moving average is $69.84. The company has a market capitalization of $3.98 billion, a P/E ratio of 19.55, a P/E/G ratio of 2.19 and a beta of 0.47. Prestige Consumer Healthcare has a fifty-two week low of $56.61 and a fifty-two week high of $81.25.
Analyst Ratings Changes
A number of research firms have recently issued reports on PBH. DA Davidson increased their target price on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a "buy" rating in a research note on Wednesday, August 28th. Jefferies Financial Group reiterated a "hold" rating and set a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $94.20.
Check Out Our Latest Stock Report on PBH
About Prestige Consumer Healthcare
(
Get Free Report)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Featured Articles
Before you consider Prestige Consumer Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prestige Consumer Healthcare wasn't on the list.
While Prestige Consumer Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
